The impact of comorbidities on recovery following hospitalisation from COVID-19.
E Daynes,M M Baldwin,U Karsanji,H Mcauley,W D Man,R Evans,S J Singh,+ On Behalf Of The Phosp Consortium,Daynes,E.,Baldwin,M. M.,Karsanji,U.,Mcauley,H.,Man,W. D.,Evans,R.,Singh,S. J.,On Behalf Of The Phosp Consortium,+
DOI: https://doi.org/10.1183/13993003.congress-2022.1714
IF: 24.3
2022-12-02
European Respiratory Journal
Abstract:Introduction: It is unknown how pre-existing comorbidities affect recovery after a hospital admission for COVID-19. Aims: To explore the impact of comorbidities on symptoms, exercise capacity and QoL 5 months after a hospital admission for COVID-19. Methods: Patients hospitalised with COVID-19 were recruited to an observational longitudinal cohort study (PHOSP-COVID). Patients were categorised into three comorbid categories (0, 1, ≥2). The Incremental Shuttle Walking Test (ISWT), FACIT, Dyspnoea-12 and the EQ5D-VAS were assessed 5 months post-discharge. Patient perceived pre-admission EQ5D-VAS scores were collected retrospectively. One-way ANOVA were used to compare groups. Results: 1516 patients completed the assessment: 61% male, mean[SD]; age 58[12], length of stay 14[19] days, BMI 32[7], number of comorbidities 2[2] with 813(53%) patients having ≥2 comorbidities. The EQ5D was reduced pre admission to 5 months for all groups (p<0.01), however the difference between pre EQ5D-VAS and at 5 months was similar between groups (p=0.18). There was a significant difference in ISWT (m, %), FACIT and EQ5D between those that had ≥2 comorbidities compared to no, and 1 comorbidity (p<0.01)(table 1). Conclusion: Although patients with more co-morbidities have a greater symptom burden and lower exercise capacity at five months post-discharge, important morbidity also persists in adults without pre-existing co-morbidity.
respiratory system